COHR insider files Form 144 to sell 2,831 shares on NYSE

Coherent Corp. insider plans a small Rule 144 stock sale.

Rhea-AI Filing Summary

Coherent Corp. insider plans a small Rule 144 stock sale. A holder has filed a notice to sell 2,831 shares of common stock of the issuer through Morgan Stanley Smith Barney LLC on the NYSE, with an aggregate market value of $381,760.35. The filing states that 157,153,611 shares of common stock were outstanding, providing context for the planned sale.

The shares to be sold were acquired on 08/28/2025 as restricted stock that vested under a registered plan from the issuer in exchange for services rendered, with payment also made on 08/28/2025. The person filing represents that they are not aware of any undisclosed material adverse information about the issuer’s current or prospective operations.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing for COHR disclose?

The notice discloses an intended sale of 2,831 shares of COHR common stock under Rule 144, with an aggregate market value of $381,760.35, to be sold on the NYSE through Morgan Stanley Smith Barney LLC.

How many COHR shares are being sold and how does that compare to shares outstanding?

The filer plans to sell 2,831 common shares. The filing notes that 157,153,611 shares of common stock were outstanding, indicating the sale is small relative to total shares.

When and how were the COHR shares being sold under Form 144 acquired?

The 2,831 common shares were acquired on 08/28/2025 as restricted stock vesting under a registered plan from the issuer in exchange for services rendered, with payment made on the same date.

When is the planned sale date for the COHR shares under this Form 144?

The filing lists an approximate date of sale of 11/21/2025 for the 2,831 common shares of COHR on the NYSE.

Which broker is handling the COHR Form 144 stock sale?

The planned sale is to be executed through Morgan Stanley Smith Barney LLC Executive Financial Services at 1 New York Plaza, 8th Floor, New York, NY 10004.

Does the COHR Form 144 filer make any representation about undisclosed information?

Yes. By signing the notice, the person for whose account the securities are to be sold represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 11/21/2025 - 04:43 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001741413
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	COHERENT CORP.
SEC File Number	001-39375
Address of Issuer	375 Saxonburg Boulevard Saxonburg PENNSYLVANIA 16056
Phone	724-352-4455
Name of Person for Whose Account the Securities are To Be Sold	ENRICO DIGIROLAMO
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	2831	381760.35	157153611	11/21/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/28/2025	Restricted stock vesting under a registered plan	Issuer			2831	08/28/2025	Services Rendered

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	11/21/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Enrico Digirolamo
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)